Sagility Ltd. reported a 22.5% increase in quarterly revenue to ₹20,321 million, driven by operational efficiency. The company improved its adjusted EBITDA margin to 26.3%, leading management to raise its full-year profit margin guidance. Investors are now tracking whether these margins can be sustained given currency volatility and the competitive nature of the healthcare outsourcing sector.
Sagility Ltd. has reported a strong performance for the second quarter of the 2027 fiscal year, with revenue climbing 22.5% compared to the same period last year, reaching ₹20,321 million. This growth was accompanied by a notable improvement in profitability, with the company achieving an adjusted EBITDA margin of 26.3%. This figure marks the company's highest margin performance in six quarters, reflecting operational improvements and favorable currency movements.
Following these results, management revised its full-year adjusted EBITDA margin guidance to a range of 25% to 26%, up from the previous forecast of 24% to 25%. This update indicates management's confidence in maintaining operational efficiency throughout the remainder of the financial year. Brokerage firm Motilal Oswal, in its recent update, noted that while profit after tax stood at ₹2,842 million, the underlying core business performance was stronger than consensus estimates when adjusting for other income.
Strategic Outlook and Growth Drivers
The company’s future growth strategy relies on increasing transaction volumes from its existing client base and winning new business contracts. As a specialized provider in the healthcare outsourcing space, Sagility focuses on managing complex processes for payers and providers, primarily in the US market. The management team is also focusing on extracting synergies from past acquisitions to help scale operations effectively. Projections from brokerage analysts suggest a compound annual growth rate of 17% in revenue and 23% in profit after tax for the period between fiscal 2026 and 2028, assuming the company continues to execute its strategy successfully.
Risks and Market Monitorables
While the company has shown strong momentum, investors should remain aware of inherent sector risks. Sagility operates in the healthcare business process management space, where success is often linked to US healthcare spending trends. Any regulatory changes or cost-cutting measures in the US healthcare system could impact client budgets, potentially affecting the company's growth.
Additionally, the IT and BPO services sector is highly sensitive to currency fluctuations, specifically the USD-INR exchange rate, which can impact margins. High employee attrition and the ability to maintain profitability while scaling are constant challenges for firms in this industry. Investors may want to closely monitor the sustainability of the current margin levels, the pace of new client acquisition, and any commentary on demand trends in the US healthcare market, which remains the primary source of revenue for the company.